Clinical Trials Logo

Filter by:
NCT ID: NCT04107844 Recruiting - Concussion, Brain Clinical Trials

Safe Return to Play After Concussion

Start date: February 10, 2020
Phase:
Study type: Observational

This study will evaluate a combination of a novel Dual-task regime together with other already known tests in terms of defining when an athlete is ready to return to play after a concussion.

NCT ID: NCT04107324 Recruiting - Liver Cancer Clinical Trials

ARAPS Study on Accelerated Liver Regeneration

ARAPS
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Liver resection is the golden standard in the treatment of hepatic malignancies. The size and function of the remnant liver is a major concern. If the future liver remnant (FLR) is below 30 % of the initial liver volume, the risk of post hepatectomy liver insufficiency rises. Several techniques have been developed to increase the size of FLR before liver resection. In this study a new technique ARAPS (portal vein embolization with radio frequency ablation) is compared to portal vein embolization alone for accelerated liver growth in the FLR. This is done in a randomized controlled trial.

NCT ID: NCT04105478 Recruiting - Clinical trials for Glenohumeral Osteoarthritis

Comparison of Stemless and Stemmed Shoulder Arthroplasty for Osteoarthritis

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This is a randomized controlled trial comparing the Comprehensive Nano stemless total shoulder arthroplasty (intervention group) with the Comprehensive un-cemented stemmed total shoulder arthroplasty (control group). All Danish citizens with glenohumeral osteoarthritis indicating a total shoulder arthroplasty referred to the orthopedic department at Copenhagen University Hospital in Gentofte will be offered participation in the trial. The following exclude from participation in the study: below 18 years of age; cognitive or linguistic impairment; insufficient function of the rotator cuff; poor bone quality and ASA group 4-5. A total of 122 patients will be included of which 56 will be part of radiostereometric analysis (RSA) study of humeral component migration. This will allow a maximum of 20% drop out. The primary outcome is magnitude and pattern of migration of the humeral component assessed by RSA. The secondary outcomes are patient-reported outcomes, functional outcome, readmission, complications, revisions, changes in bone mineral density (BMD) of the proximal humerus assessed by duel energy x-ray absorptiometry (DXA) and economy (cost utility analysis). To avoid bias in some of these outcomes, the patient will not know what type of humeral component was used. The patients are examined before the operation and 3, 6, 12 and 24 months after the operation.

NCT ID: NCT04105231 Recruiting - Dual Diagnosis Clinical Trials

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

Start date: June 1, 2021
Phase: Phase 2
Study type: Interventional

This trial examines the efficacy of cannabidiol (CBD) versus risperidone for treatment of psychosis in patients with non affective-psychosis and lifetime use of cannabis.

NCT ID: NCT04104178 Recruiting - MRSA Clinical Trials

Optimal Treatment of MRSA Throat Carriers

Start date: May 20, 2020
Phase: Phase 3
Study type: Interventional

The aim of this study is to investigate the optimal way to treat MRSA throat carriers.

NCT ID: NCT04098939 Recruiting - Diaphragm Disease Clinical Trials

Evaluation of Diaphragm Movement

Start date: May 1, 2020
Phase:
Study type: Observational

Precise measurement of diaphragm function is difficult. Several methods exist. No are sufficiently validated. With this study, the investigators wish to investigate the validity of different ultrasound and radiological methods and compare them with inspiratory pressure measurements.

NCT ID: NCT04098510 Recruiting - Healthy Clinical Trials

Concentration of MitoQ in Human Skeletal Muscle

MitoQ/muscle
Start date: September 8, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.

NCT ID: NCT04095676 Recruiting - Pleural Empyema Clinical Trials

VATS Surgery Compared to Drainage in the Treatment of Pleural Empyema

FIVERVATS
Start date: October 30, 2022
Phase: N/A
Study type: Interventional

Pleura empyema is a frequent disease with a high morbidity and a mortality rate of approximately 15%. Pleura empyema is characterized by the passage of three stages (I - III). The aim of treating the disease is to remove the infection and provide fully expansion of the lung. The initial treatment at the early stage of the disease (stage I) is simple drainage. In clinical practice, stages II and III are treated alike. Current standard treatment for these stages is drainage with ultrasound (ULS) -guided pigtail. Simultaneously with drainage, an intrapleural fibrinolyticum can be given. A potential better alternative is surgery in terms of Video Assisted Thoracoscopic Surgery (VATS). The theoretical advantage of early surgery is that patients undergo rapid, definitive treatment. Furthermore, surgery can ensure optimal drain placement. How best to treat these patients (drainage or surgery) is still under clinical evaluation and depends to a great extent on local clinical practice. It is only to a limited extent based on scientific evidence. The aim of this study is to determine if there is a difference in outcome in patients diagnosed with stage II and stage III empyema who either receive primary VATS surgery or ULS guided drainage and intrapleural therapy (fibrinolytic (altaplasm) with DNase (Pulmozyne ®)) The primary outcome is Hospitalization time and secondary outcomes is e.g. mortality, health related costs and quality of life. The present study can thus provide new and highly relevant knowledge as well as change the treatment of these patients, both nationally and internationally. It is planned that a total of 184 patients will be included in the project. The study takes place as a collaboration between all four thoracic surgical departments and the major pulmonary medicine departments in Denmark. In addition, the study has international collaborators/consultants who will provide counselling in connection with the study.

NCT ID: NCT04095299 Recruiting - Cancer of Rectum Clinical Trials

Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients

WW3
Start date: January 20, 2020
Phase: Phase 2
Study type: Interventional

In recent years, an increasing number of retrospective and prospective observational studies have indicated that a subset of rectal cancer patients may avoid surgery if they can achieve a complete response to chemoradiotherapy. Prospective trials, including the previous Danish Watchful Waiting trials (NCT00952926, NCT02438839) in early rectal cancer have demonstrated high levels of organ preservation with dose-escalation, but it is unclear whether this was primarily due to tumor stage or dose level. The aim of the present study is to investigate if a higher dose of radiotherapy is superior compared to a standard dose in patients with early rectal cancer undergoing chemoradiotherapy with curative intent.

NCT ID: NCT04094636 Recruiting - Clinical trials for Community-acquired Pneumonia

Physical Training During Hospital Admission With Community-Acquired Pneumonia

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of standard usual care combined with daily supervised physical training during hospitalization with community-acquired pneumonia (CAP) compared to standard usual care alnone.